Application of baicalin in treatment of acute pancreatitis
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 张喜平
- Publication Date
- 2006-02-22
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The present invention relates to the application of baicalin (glycoside), especially the application of baicalin in the treatment of acute pancreatitis. Background technique
[0002] Baicalin (glycoside) is a flavonoid compound. At present, there is no baicalin (glycoside) liquid officially approved by the State Food and Drug Administration for clinical use, and baicalin (glycoside) has many pharmacological activities. It is effective in scavenging oxygen free radicals. , reduce tissue ischemia-reperfusion injury, regulate immune function, protect liver and gallbladder, anti-infection, anti-tumor and other aspects have certain effects. The composition of baicalin (glycoside) has good solubility and low toxicity, and has potential clinical development and application value. Contents of the invention
[0003] The purpose of the present invention is to provide a new application of baicalin (glycoside), that is, the application in the treatment of acute...